Literature DB >> 27671812

Emodin and Its Role in Chronic Diseases.

B Anu Monisha1, Niraj Kumar2, Ashu Bhan Tiku3.   

Abstract

Diseases, such as heart disease, stroke, cancer, respiratory diseases, and diabetes, are by far the leading cause of mortality in the world, representing 60 % of all deaths. Although substantial medical advances have been made and many therapeutic approaches proposed yet traditional medicine and medicinal plants find an important place in therapy. They have been providing invaluable solutions to the various health problems. Emodin (1,3,8-trihydroxy-6-methylanthraquinone) is a natural anthraquinone derivative found in various Chinese medicinal herbs. Traditionally, it has been used as an active constituent of many herbal laxatives. However, in the last few years, significant progress has been made in studying the biological effects of emodin at cellular and molecular levels and it is emerging as an important therapeutic agent. This review provides an overview of the modulatory effects of emodin in various diseases and cell signaling pathways, which may have important implications in its future clinical use.

Entities:  

Keywords:  Anthraquinone; Bioavailability; Cancer; Chemosesitizer; Emodin; Radiosensitizer

Mesh:

Substances:

Year:  2016        PMID: 27671812     DOI: 10.1007/978-3-319-41334-1_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Emodin Attenuates Acetaminophen-Induced Hepatotoxicity via the cGAS-STING Pathway.

Authors:  Pan Shen; Liang Han; Guang Chen; Zhe Cheng; Qiong Liu
Journal:  Inflammation       Date:  2021-08-18       Impact factor: 4.092

2.  Emodin suppresses hepatocellular carcinoma growth by regulating macrophage polarization via microRNA-26a/transforming growth factor beta 1/protein kinase B.

Authors:  Jiao Yin; Xiansheng Zhao; Xuejiao Chen; Guanxin Shen
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Emodin Reduces the Activity of (1,3)-β-D-glucan Synthase from Candida albicans and Does Not Interact with Caspofungin.

Authors:  Monika Janeczko
Journal:  Pol J Microbiol       Date:  2018

4.  Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism.

Authors:  Young-Seon Kim; Yoon-Mi Lee; Taek-In Oh; Dong Hoon Shin; Geon-Hee Kim; Sang-Yeon Kan; Hyeji Kang; Ji Hyung Kim; Byeong Mo Kim; Woo Jong Yim; Ji-Hong Lim
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

5.  Emodin alleviates CCl4‑induced liver fibrosis by suppressing epithelial‑mesenchymal transition and transforming growth factor‑β1 in rats.

Authors:  Feng Liu; Jing Zhang; Jianmin Qian; Gang Wu; Zhenyu Ma
Journal:  Mol Med Rep       Date:  2018-07-26       Impact factor: 2.952

6.  Interactions Between Emodin and Efflux Transporters on Rat Enterocyte by a Validated Ussing Chamber Technique.

Authors:  Juan Huang; Lan Guo; Ruixiang Tan; Meijin Wei; Jing Zhang; Ya Zhao; Lu Gong; Zhihai Huang; Xiaohui Qiu
Journal:  Front Pharmacol       Date:  2018-06-22       Impact factor: 5.810

7.  Emodin reactivated autophagy and alleviated inflammatory lung injury in mice with lethal endotoxemia.

Authors:  Yan Dong; Li Zhang; Yu Jiang; Jie Dai; Ling Tang; Gang Liu
Journal:  Exp Anim       Date:  2019-07-11

Review 8.  Hypoxia-Inducible Factor-1: A Potential Target to Treat Acute Lung Injury.

Authors:  Yang Liu; Du Xiang; Hengcheng Zhang; Hanlin Yao; Yanfeng Wang
Journal:  Oxid Med Cell Longev       Date:  2020-11-17       Impact factor: 6.543

9.  Kanglexin delays heart aging by promoting mitophagy.

Authors:  Hui-Min Li; Xin Liu; Zi-Yu Meng; Lei Wang; Li-Min Zhao; Hui Chen; Zhi-Xia Wang; Hao Cui; Xue-Qing Tang; Xiao-Han Li; Wei-Na Han; Xue Bai; Yuan Lin; Heng Liu; Yong Zhang; Bao-Feng Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

Review 10.  Coptisine from Coptis chinensis exerts diverse beneficial properties: A concise review.

Authors:  Jiasi Wu; Yu Luo; Donghang Deng; Siyu Su; Sheng Li; Li Xiang; Yingfan Hu; Ping Wang; Xianli Meng
Journal:  J Cell Mol Med       Date:  2019-10-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.